您当前的位置：
首页 >
文章列表页 >
Mechanism of Medicated Serum of Buyang Huanwutang in Inhibiting Endothelial-to-mesenchymal Transition of Human Pulmonary Artery Endothelial Cells Based on Wnt1/β-catenin Signaling Pathway
更新时间：2024-03-04

    • Mechanism of Medicated Serum of Buyang Huanwutang in Inhibiting Endothelial-to-mesenchymal Transition of Human Pulmonary Artery Endothelial Cells Based on Wnt1/β-catenin Signaling Pathway

    • “In the field of pulmonary artery endothelial cell endothelial mesenchymal transition research, experts have verified the inhibitory effect of Buyang Huanwu Tang drug containing serum on transformation, providing a solution for regulating the Wnt/β - catenin signaling pathway.”
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 30, Issue 7, Pages: 49-58(2024)

    • DOI：10.13422/j.cnki.syfjx.20232041    

      CLC： R2-0;R33;R289;R563

    • Received：28 August 2023，

      Published Online：08 December 2023，

      Published：05 April 2024

    移动端阅览

  • YANG Qifen,QU Jinglian,ZHAO Huiliang,et al.Mechanism of Medicated Serum of Buyang Huanwutang in Inhibiting Endothelial-to-mesenchymal Transition of Human Pulmonary Artery Endothelial Cells Based on Wnt1/β-catenin Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(07):49-58. DOI： 10.13422/j.cnki.syfjx.20232041.

  •  
  •  

0

Views

77

下载量

2

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Effect of Serum Containing Buyang Huanwu Tang on Endothelial-to-mesenchymal Transition of Human Pulmonary Artery Endothelial Cells
Ameliorating Effect of Yifei Tongluo Prescription on Bleomycin-induced Pulmonary Fibrosis in Rats via Regulating NLRP3/Caspase-1/GSDMD Signaling Pathway and Epithelial-mesenchymal Transition
Modern Research and Application Characteristics of Inhalation Treatment for Chronic Lung Diseases
Shengxiantang Alleviates Idiopathic Pulmonary Fibrosis in Rats by Regulating Oxidative Stress to Inhibit PANoptosis

Related Author

Jing-lian QU
Han-jie YANG
Hui-liang ZHAO
ZHOU Bowen
LI Zefeng
MA Xian
LI Xuannian
WANG Jingwen

Related Institution

Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Shandong University of Traditional Chinese Medicine
Linshu County People's Hospital
Qingdao Hospital of Traditional Chinese Medicine
School of Pharmacy， Academy of Chinese Medical Sciences， Henan University of Chinese Medicine
0